Efficacy and Safety of Canagliflozin in Individuals Aged 75 and Older with Type 2 Diabetes Mellitus: A Pooled Analysis

OBJECTIVES: To compare the efficacy and safety of canagliflozin, a sodium glucose co‐transporter 2 inhibitor developed to treat type 2 diabetes mellitus (T2DM), in individuals younger than 75 and those aged 75 and older. DESIGN: Randomized Phase 3 studies. SETTING: International study centers. PARTI...

Descripción completa

Detalles Bibliográficos
Autores principales: Sinclair, Alan J., Bode, Bruce, Harris, Stewart, Vijapurkar, Ujjwala, Shaw, Wayne, Desai, Mehul, Meininger, Gary
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2016
Materias:
Clinical Investigations
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4819884/
https://www.ncbi.nlm.nih.gov/pubmed/27000327
http://dx.doi.org/10.1111/jgs.14028

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4819884/
https://www.ncbi.nlm.nih.gov/pubmed/27000327
http://dx.doi.org/10.1111/jgs.14028

Ejemplares similares